Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Rosetta Exosome Co. Ltd. currently has 1 pending office action within the Chemistry & Materials technology area. This single matter is assigned to a distinct examiner and is located within a distinct art unit. The company's current prosecution activity is entirely focused on this one case.
The busiest examiner for the portfolio is DRODGE, JOSEPH W, who is responsible for 1 pending office action. This represents the total active workload for the company at the USPTO. For a practitioner, this means that all efforts can be concentrated on this single point of contact, simplifying the management of the case.
The involvement of a distinct art unit indicates a narrow technical focus for the current pending matter. With 1 pending office action and a distinct examiner, there are no other active files to coordinate or conflicting deadlines to manage. The prosecution strategy for this active action can be specifically tailored to the requirements and feedback of the assigned examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DRODGE, JOSEPH W | 1 | 78.3% | +38.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18573095 | COMMERCIAL PURIFICATION METHOD FOR HIGH-PURITY BACTERIAL EXTRACELLULAR VESICLES | DRODGE, JOSEPH W | 7d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18573095 | COMMERCIAL PURIFICATION METHOD FOR HIGH-PURITY BACTERIAL EXTRACELLULAR VESICLES | DRODGE, JOSEPH W | 7d |
| Art Unit | Apps |
|---|---|
| 1773 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18573095 | COMMERCIAL PURIFICATION METHOD FOR HIGH-PURITY BACTERIAL EXTRACELLULAR VESICLES | DRODGE, JOSEPH W | 1773 | §102§103§112Other | Final Rejection | 7d | Pending | Dec 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRosetta Exosome Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Joseph W Drodge has the most, with 1 of Rosetta Exosome Co. Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.